UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 13, pp. 1480 - 1487
Allergy and Immunology | Inactivated quadrivalent influenza vaccine | Seasonal influenza | Yamagata lineage | Victoria lineage | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Microbiology | Applied microbiology | Influenza A Virus, H3N2 Subtype | Double-Blind Method | Influenza Vaccines - classification | Humans | Middle Aged | Male | Influenza B virus | Antibodies, Viral - blood | Hemagglutination Inhibition Tests | Young Adult | Adolescent | Aged, 80 and over | Antibody Formation | Influenza A Virus, H1N1 Subtype | Influenza Vaccines - therapeutic use | Adult | Female | Aged | Vaccines, Inactivated - therapeutic use | Influenza, Human - prevention & control | Influenza vaccines | Product development | Adults | Influenza | Public health | Confidence intervals | Immunization | Vaccines | Seasons | Index Medicus
Journal Article
The Pediatric infectious disease journal, ISSN 0891-3668, 11/2016, Volume 35, Issue 11, pp. 1232 - 1241
Journal Article
BMC infectious diseases, ISSN 1471-2334, 07/2013, Volume 13, Issue 1, pp. 343 - 343
Seasonal influenza | Quadrivalent | Trivalent | Non-inferiority | Superiority | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Influenza A Virus, H1N1 Subtype - immunology | Influenza Vaccines - administration & dosage | Humans | Middle Aged | Influenza Vaccines - adverse effects | Male | Influenza A Virus, H3N2 Subtype - immunology | Antibodies, Viral - blood | Hemagglutination Inhibition Tests | Young Adult | Vaccines, Inactivated - adverse effects | Vaccines, Inactivated - immunology | Influenza Vaccines - immunology | Vaccines, Inactivated - administration & dosage | Adolescent | Aged, 80 and over | Adult | Female | Influenza A virus - immunology | Aged | Influenza B virus - immunology | Influenza, Human - prevention & control | Influenza vaccines | Antigens | Medical research | Immune response | Vaccination | Medicine, Experimental | Biological products industry | Product development | Immunization | Hospitalization | Vaccines | Seasons | Preventive medicine | Influenza | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2020, Volume 324, Issue 10, pp. 951 - 960
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Coronavirus Infections - prevention & control | Immunogenicity, Vaccine | Adjuvants, Immunologic - administration & dosage | Dose-Response Relationship, Immunologic | Humans | Pandemics - prevention & control | Male | Aluminum Hydroxide - administration & dosage | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Betacoronavirus - immunology | COVID-19 | Young Adult | SARS-CoV-2 | Adult | Female | Double-Blind Method | Propiolactone | Injections, Intramuscular | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Viral Vaccines - administration & dosage | Vaccines, Inactivated - immunology | Aluminum Hydroxide - adverse effects | Pneumonia, Viral - prevention & control | COVID-19 Vaccines | Adolescent | Betacoronavirus - genetics | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Schedules | Aluminum | Vaccination | Viral diseases | Clinical trials | Antibodies | Viruses | Vaccines | Antibody response | Pain | Safety | Immunization | Severe acute respiratory syndrome | Injection | Coronaviruses | Fever | Severe acute respiratory syndrome coronavirus 2 | Side effects | Injections | Immunogenicity | Neutralizing | Aluminum hydroxide | Adults | Alum | Neutralization
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 07/2020, Volume 369, Issue 6499, pp. 77 - 81
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | Immunogenicity, Vaccine | Dose-Response Relationship, Immunologic | Immunoglobulin G - blood | Rats, Wistar | Pandemics - prevention & control | Male | Macaca mulatta | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Viral Load | Betacoronavirus - immunology | COVID-19 | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Immunoglobulin G - biosynthesis | Immunoglobulin G - immunology | Female | Vero Cells | Antibodies, Viral - biosynthesis | Chlorocebus aethiops | Betacoronavirus - isolation & purification | Rats | Coronavirus Infections - immunology | Viral Vaccines - administration & dosage | Vaccines, Inactivated - adverse effects | Pilot Projects | Vaccines, Inactivated - immunology | Animals | Coronavirus Infections - virology | Vaccines, Inactivated - administration & dosage | Antibodies, Neutralizing - biosynthesis | Pneumonia, Viral - prevention & control | COVID-19 Vaccines | Antibodies, Viral - immunology | Mice | Mice, Inbred BALB C | Pneumonia, Viral - virology | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Medical research | Immunization | Pandemics | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Infections | Monkeys | Vaccines | Coronaviruses | Dosage | Pharynx | Severe acute respiratory syndrome coronavirus 2 | Neutralizing | Respiratory diseases | Primates | Strains (organisms) | Public health | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 617 - 624
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Influenza Vaccines - administration & dosage | Humans | Vaccination | Influenza Vaccines - adverse effects | Child, Preschool | Immunity, Herd | Influenza, Human - epidemiology | Vaccines, Inactivated - adverse effects | Canada - epidemiology | Vaccines, Inactivated - administration & dosage | Rural Population | Vaccines, Attenuated - administration & dosage | Adolescent | Vaccines, Attenuated - adverse effects | Child | Influenza, Human - prevention & control | Influenza vaccines | Prevention | Children | Comparative analysis | Hutterian Brethren | Health aspects | Diseases | Clinical trials | Vaccines | Influenza | Childrens health | Index Medicus | Abridged Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 09/2017, Volume 35, Issue 40, pp. 5314 - 5322
Pregnancy | Spontaneous abortion | Influenza vaccine | Influenza | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Influenza A Virus, H1N1 Subtype - immunology | Humans | Influenza Vaccines - adverse effects | Influenza A Virus, H1N1 Subtype - pathogenicity | Case-Control Studies | Young Adult | Vaccines, Inactivated - adverse effects | Vaccines, Inactivated - immunology | Abortion, Spontaneous - etiology | Influenza Vaccines - therapeutic use | Adult | Female | Vaccines, Inactivated - therapeutic use | Odds Ratio | Influenza, Human - prevention & control | Influenza, Human - immunology | Influenza vaccines | Miscarriage | Abortion | Influenza viruses | Prevention | Antigens | Analysis | Vaccination | Medical records | Menstruation | Womens health | Exposure | Vaccines | Safety | Health risk assessment | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 10, pp. 1289 - 1295
Allergy and Immunology | Hantavirus | Safety | Immunogenicity | Hantaan virus vaccines | NCT02360514 | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Hantaan virus | Humans | Middle Aged | Male | Neutralization Tests | Hemorrhagic Fever with Renal Syndrome - prevention & control | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Viral Vaccines - administration & dosage | Young Adult | Vaccines, Inactivated - adverse effects | Vaccines, Inactivated - immunology | Immunization, Secondary | Vaccines, Inactivated - administration & dosage | Adult | Female | Aged | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Vaccination | Safety and security measures | Vaccines | Confidence intervals | Viruses | Immunization | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 9, pp. 829 - 837
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Enterovirus A, Human - genetics | Double-Blind Method | Humans | Vaccines, Inactivated | Enterovirus A, Human - immunology | Hand, Foot and Mouth Disease - immunology | Kaplan-Meier Estimate | Child, Preschool | Infant | Male | Injections, Intramuscular | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Viral Vaccines - administration & dosage | Hand, Foot and Mouth Disease - prevention & control | China | Fever - etiology | Hand, Foot and Mouth Disease - epidemiology | Female | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Prevention | Demographic aspects | Dosage and administration | Research | Vaccines | Children | Planning | Health aspects | Enterovirus diseases | Medical research | Genotype & phenotype | Immune response | Motivation | Foot & mouth disease | Vaccination | Hand-foot-and-mouth disease | Seroconversion | Drug dosages | Fever | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 11/2010, Volume 51, Issue 9, pp. 997 - 1004
Influenza vaccines | Cell culture techniques | Immune response | Vaccination | Cell lines | Placebos | Viruses | Cultured cells | Orthomyxoviridae | ARTICLES AND COMMENTARIES | Diseases | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Viral diseases of the respiratory system and ent viral diseases | Infectious diseases | Medical sciences | Human viral diseases | Viral diseases | Influenza Vaccines - administration & dosage | United States | Humans | Middle Aged | Male | Orthomyxoviridae - immunology | Young Adult | Technology, Pharmaceutical | Poland | Adult | Female | Vaccines, Subunit - adverse effects | Cell Culture Techniques | Placebos - administration & dosage | Nasal Mucosa - virology | Influenza Vaccines - adverse effects | Pharynx - virology | Vaccines, Subunit - immunology | Vaccines, Inactivated - adverse effects | Vaccines, Inactivated - immunology | Influenza Vaccines - immunology | Vaccines, Inactivated - administration & dosage | Vaccines, Subunit - administration & dosage | Adolescent | Finland | Orthomyxoviridae - genetics | Influenza, Human - prevention & control | Orthomyxoviridae - isolation & purification | Prevention | Cell culture | Usage | Influenza | Physiological aspects | Research | Health aspects | Immunization | Adults | Vaccines | Index Medicus
Journal Article